Find a clinic
Questions about treatments
Questions about our technologies or workstations
General inquiries email or call 1.855.411.2639
WHAT IS ENVISION?
Envision is the new in-office standard revolutionizing procedures in delicate areas. This ground breaking, nonsurgical device, allow for safe and highly efficacious procedures in the small, more delicate subdermal layers of the periorbital region. With Envision, practitioners deliver non-drug therapies to improve patient quality of life.
KEY BENEFITS:
Envision deploys multiple complementary modalities which work synergistically:
- Forma-I: bipolar radiofrequency (RF)
- Lumecca-I: intense pulse light (IPL)
- Morpheus8: subdermal adipose tissue remodeling (SARD)
Small-size applicators and precise depth control allow for procedures in the small, more delicate subdermal layers of the periorbital region
Perform safe and effective, nonsurgical, office-based procedures to improve meibomian gland function and reduce dry eye symptoms*
*Health Canada certified indications for use.
TECHNOLOGIES ON THE WORKSTATION
Forma-I is a treatment to address the symptoms of dry eye disease caused by Meibomian Gland Dysfunction (MGD). It is intended for use in the periorbital area and eyelids and relieves inflammation of meibomian glands and eye irritation*.
*Health Canada certified indications for use.
Lumecca-I ensures precise, targeted, spot-size Intense Pulsed Light (IPL) procedures to treat inflammatory conditions in smaller zones. This technology was developed with an advanced xenon flash lamp and is optimized for light and dark skin tones.
Morpheus8 is a minimally invasive device for fractional coagulation of subcutaneous tissue. Morpheus8 provides an interchangeable portfolio of microneedling tips to deliver customizable fractional treatments.
Approved intended use varies by country; please check with local providers or representatives. Individual treatment results may vary.
Clinical and peer-reviewed publications are published by a third party and based on physician experiences and study results. InMode does not take responsibility for or endorse the content provided by the independent practitioners as the language may differ than InMode manufacturer clearances.

ENVISION by InMode